Regulation of clotting cascade

Stable Identifier
R-HSA-9769739
Type
Pathway
Species
Homo sapiens
ReviewStatus
3/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this pathway in the Pathway Browser
The coagulation pathway is tightly regulated by numerous mechanisms to maintain hemostatic balance and ensure effective clot formation. Dysregulation of any component can lead to bleeding or thrombotic disorders. This Reactome module describes key endogenous regulators of the clotting pathway, including:
  • Tissue factor pathway inhibitor (TFPI): Forms a quaternary complex with FXa, FVIIa and TF, effectively inactivating FXa and FVIIa to restrict coagulation during the initiation phase (Broze GJ et al., 1990; Maroney SA et al., 2013).
  • Protein C: Activated by the thrombin–thrombomodulin complex on intact endothelial cells. Together with its cofactor, protein S, it inhibits FVa and FVIIIa activities, contributing to anticoagulation (Stavenuiter F et al., 2013).
  • Serine endopeptidase inhibitors, including SERPINC1 (antithrombin III), SERPINA5, SERPINA10 and SERPIND1: Inactivate serine proteases such as thrombin and FXa by irreversibly binding to their serine activation sites (Mushunje A et al., 2003; Boulaftali Y et al., 2010; Huang X et al., 2010).
  • A disintegrin and metalloproteinase with thrombospondin motifs 13 (ADAMTS13): A metalloprotease, that regulates thrombus formation by cleaving VWF multimers on the platelet surface or in the circulation in the presence of factor VIII (Cao W et al., 2008; DeYoung V et al., 2022;
  • This Reactome module also highlights selected drugs that target clotting factors or their regulators to promote effective clot formation (Petersen LC 2012; Nutescu EA et al., 2016).

    Literature References
    PubMed ID Title Journal Year
    2271516 Regulation of coagulation by a multivalent Kunitz-type inhibitor

    Broze, GJ Jr, Girard, TJ, Novotny, WF

    Biochemistry 1990
    24741378 Down-regulation of the clotting cascade by the protein C pathway

    Stavenuiter, F, Bouwens, EA, Mosnier, LO

    Hematol Educ 2013
    12907439 Heparin-induced substrate behavior of antithrombin Cambridge II

    Mushunje, A, Zhou, A, Carrell, RW, Huntington, JA

    Blood 2003
    20427285 Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa

    Huang, X, Dementiev, A, Olson, ST, Gettins, PG

    J Biol Chem 2010
    18492805 Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13

    Cao, W, Krishnaswamy, S, Camire, RM, Lenting, PJ, Zheng, XL

    Proc Natl Acad Sci U S A 2008
    19855083 Anticoagulant and antithrombotic properties of platelet protease nexin-1

    Boulaftali, Y, Adam, F, Venisse, L, Ollivier, V, Richard, B, Taieb, S, Monard, D, Favier, R, Alessi, MC, Bryckaert, M, Arocas, V, Jandrot-Perrus, M, Bouton, MC

    Blood 2010
    Participants
    Events
    Participates
    Orthologous Events
    Authored
    Created
    Cite Us!